Brian G Atwood's Net Worth

-$28.7 Thousand

Who is Brian G Atwood?

Brian G Atwood does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., INSULET CORP, PHASERX, INC., Trius Therapeutics Inc, PHARMION CORP, XENOGEN CORP, GLAUKOS Corp, VERACYTE, INC., CERO THERAPEUTICS HOLDINGS, INC., Clovis Oncology, Inc., OPGEN INC, Inogen Inc, Atreca, Inc., SECOND SIGHT MEDICAL PRODUCTS INC, Locust Walk Acquisition Corp., NOVACEA INC, GENOMIC HEALTH INC, CADENCE PHARMACEUTICALS INC, FIVE PRIME THERAPEUTICS INC, INTRALASE CORP, Alexza Pharmaceuticals Inc., HELICOS BIOSCIENCES CORP, Flexion Therapeutics Inc, and Launch One Acquisition Corp..

SEC CIK

Brian G Atwood's CIK is 0001266567

Past Insider Trading and Trends

2016 was Brian G Atwood's most active year for acquiring shares with 5 total transactions. Brian G Atwood's most active month to acquire stocks was the month of May. 2008 was Brian G Atwood's most active year for disposing of shares, totalling 9 transactions. Brian G Atwood's most active month to dispose stocks was the month of February. 2020 saw Brian G Atwood paying a total of $21,239.68 for 59,034 shares, this is the most they've acquired in one year. In 2013 Brian G Atwood cashed out on 60,302 shares for a total of $483,807.42, their largest year based on trade value.